The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies

Lignende værker

• Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.
  af: Kempf, D J, et al.
  Udgivet: (1997)
• Ritonavir-Saquinavir Dual Protease Inhibitor Compared to Ritonavir Alone in Human Immunodeficiency Virus-Infected Patients
  af: Michelet, Christian, et al.
  Udgivet: (2001)
• Effects of the Human Immunodeficiency Virus-Protease Inhibitor, Ritonavir, on Basal and Catecholamine-Stimulated Lipolysis
  af: Adler-Wailes, Diane C., et al.
  Udgivet: (2005)
• In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates.
  af: Chong, K T, et al.
  Udgivet: (1997)
• Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
  af: Bechtold, C M, et al.
  Udgivet: (1995)